Magnetic bead-based proteomic technology to study paricalcitol effect in kidney transplant recipients

European Journal of Pharmacology

Volumn 709, Issue 1-3, 2013, Pages 72-79

  Pérez, Vanessa ^a,b   Sánchez Escuredo, Anna ^a   Lauzurica, Ricardo ^a   Bayés, Beatriu ^a   Navarro Muñoz, Maribel ^a,b   Pastor, María Cruz ^a   Cañas, Laura ^a   Bonet, Josep ^a,b   Romero, Ramón ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bradykinin; Complement C4; Kidney transplantation; Paricalcitol; Plasma peptidome; Proteomics

Indexed keywords

ALKALINE PHOSPHATASE; BRADYKININ; CALCINEURIN INHIBITOR; CALCIUM; COMPLEMENT COMPONENT C4; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; PARICALCITOL; PREDNISONE; TACROLIMUS;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID SEQUENCE; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; BRADYKININ; COMPLEMENT C4; ERGOCALCIFEROLS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC PHENOMENA; MALE; MICROSPHERES; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEOMICS; RECEPTORS, CALCITRIOL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84877019960     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.03.040     Document Type: Article

References (40)

1. R. Agarwal, M. Acharya, J. Tian, R.L. Hippensteel, J.Z. Melnick, P. Qiu, L. Williams, and D. Batlle Antiproteinuric effect of oral paricalcitol in chronic kidney disease Kidney Int. 68 2005 2823 2828
2. R. Agarwal, J.E. Hynson, T.J. Hecht, R.P. Light, and A.D. Sinha Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate Kidney Int. 80 2011 1073 1079
3. P. Alborzi, N.A. Patel, C. Peterson, J.E. Bills, D.M. Bekele, Z. Bunaye, R.P. Light, and R. Agarwal Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial Hypertension 52 2008 249 255
4. R.M. Barnes, C.A. Hart, L.C. Alexander, and S. Steen Immunological evaluation of renal transplant patients: changes in levels of beta-2-microglobulin, immunoglobulins and complement components during graft rejection J. Clin. Lab. Immunol. 12 1983 17 22
5. S. Baumann, U. Ceglarek, G.M. Fiedler, J. Lembcke, A. Leichtle, and J. Thiery Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Clin Chem. 51 2005 973 980
6. K.D. Bhoola, C.D. Figueroa, and K. Worthy Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol. Rev. 44 1992 1 80
7. M.J. Blayney, R.L. Pisoni, J.L. Bragg-Gresham, J. Bommer, L. Piera, A. Saito, T. Akiba, M.L. Keen, E.W. Young, and F.K. Port High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death Kidney Int. 74 2008 655 663
8. M. Cozzolino, D. Brancaccio, G. Cannella, P. Messa, L. Gesualdo, M. Marangella, C. Lodeserto, M. Pozzato, G. Rombola, A.M. Costanzo, U. di Luzio Paparatti, and S. Mazzaferro VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH<=150 pg/mL: results of the Italian FARO Survey Nephrol. Dial. Transplant. 27 2012 3588 3594
9. J. Cheng, W. Zhang, X. Zhang, X. Li, and J. Chen Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis Clin. J. Am. Soc. Nephrol. 7 2012 391 400
10. O.I. Egbuna, J.G. Taylor, D.A. Bushinsky, and M.S. Zand Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure Clin. Transplant. 21 2007 558 566
11. K.M. Ellis, and J.R. Fozard Species differences in bradykinin receptor-mediated responses of the airways Auton. Autacoid Pharmacol. 22 2002 3 16
12. G.M. Fiedler, S. Baumann, A. Leichtle, A. Oltmann, J. Kase, J. Thiery, and U. Ceglarek Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Clin. Chem. 53 2007 421 428
13. J.E. Figueroa, and P. Densen Infectious diseases associated with complement deficiencies Clin. Microbiol. Rev. 4 1991 359 395
14. W. Gwinner, S. Suppa, M. Mengel, L. Hoy, H.H. Kreipe, H. Haller, and A. Schwarz Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications Am. J. Transplant. 5 2005 1934 1941
15. J.M. Hall Bradykinin receptors Gen. Pharmacol. 28 1997 1 6
16. J. Jokihaara, I. Porsti, I. Pajamaki, T. Vuohelainen, P. Jolma, P. Koobi, J. Kalliovalkama, O. Niemela, P. Kannus, H. Sievanen, and T.L. Jarvinen Paricalcitol [19-nor-1,25-(OH)2D2] in the treatment of experimental renal bone disease J. Bone Miner. Res. 21 2006 745 751
17. C.P. Kovesdy, and K. Kalantar-Zadeh Vitamin D receptor activation and survival in chronic kidney disease Kidney Int. 73 2008 1355 1363
18. R. Marcucci, M. Zanazzi, E. Bertoni, T. Brunelli, S. Fedi, L. Evangelisti, G. Pepe, A. Rogolino, D. Prisco, R. Abbate, G.F. Gensini, and M. Salvadori Risk factors for cardiovascular disease in renal transplant recipients: new insights Transplant Int. 13 Suppl. 1 2000 S419 S424
19. M.M. Markiewski, and J.D. Lambris The role of complement in inflammatory diseases from behind the scenes into the spotlight Am. J. Pathol. 171 2007 715 727
20. K.J. Martin, E.A. Gonzalez, M. Gellens, L.L. Hamm, H. Abboud, and J. Lindberg 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis J. Am. Soc. Nephrol. 9 1998 1427 1432
21. P. Messa, C. Sindici, G. Cannella, V. Miotti, A. Risaliti, M. Gropuzzo, P.L. Di Loreto, F. Bresadola, and G. Mioni Persistent secondary hyperparathyroidism after renal transplantation Kidney Int. 54 1998 1704 1713
22. C. Mitterbauer, and R. Oberbauer Bone disease after kidney transplantation Transplant Int. 21 2008 615 624
23. T. Nilsson, M. Mann, R. Aebersold, J.R. Yates 3rd, A. Bairoch, and J.J. Bergeron Mass spectrometry in high-throughput proteomics: ready for the big time Nat. Methods 7 2010 681 685
24. J.W. Park, E.H. Bae, I.J. Kim, S.K. Ma, C. Choi, J. Lee, and S.W. Kim Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats Am. J. Physiol. Renal Physiol. 298 2009 F301 F313
25. V. Perez, M. Navarro-Munoz, S. Mas, B. Bayes, M.C. Pastor, E. Martinez-Caceres, R. Lauzurica, J. Egido, and R. Romero Proteomic approach to the study of statin pleiotropy in kidney transplant patients Pharmacology 87 2011 161 168
26. V. Perez, A. Sanchez, B. Bayes, M. Navarro-Munoz, R. Lauzurica, M.C. Pastor, and R. Romero Effect of paricalcitol on the urinary peptidome of kidney transplant patients Transplant Proc. 42 2010 2924 2927
27. D.L. Regidor, C.P. Kovesdy, R. Mehrotra, M. Rambod, J. Jing, C.J. McAllister, D. Van Wyck, J.D. Kopple, and K. Kalantar-Zadeh Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients J. Am. Soc. Nephrol. 19 2008 2193 2203
28. R. Richter, P. Schulz-Knappe, M. Schrader, L. Standker, M. Jurgens, H. Tammen, and W.G. Forssmann Composition of the peptide fraction in human blood plasma: database of circulating human peptides J. Chromatogr. B Biomed. Sci. Appl. 726 1999 25 35
29. M. Schrader, and P. Schulz-Knappe Peptidomics technologies for human body fluids Trends Biotechnol. 19 2001 S55 60
30. G.K. Sonkar, and R.G. Singh Study on the role of humoral immunity in renal transplant rejections and its correlation with histopathological findings Saudi J. Kidney Dis. Transplant. 22 2011 901 910
31. S.M. Sprague, V. Belozeroff, M.D. Danese, L.P. Martin, and K. Olgaard Abnormal bone and mineral metabolism in kidney transplant patients - a review Am. J. Nephrol. 28 2008 246 253
32. S.M. Sprague, and M.A. Josephson Bone disease after kidney transplantation Semin. Nephrol. 24 2004 82 90
33. A. Stavroulopoulos, M.J. Cassidy, C.J. Porter, D.J. Hosking, and S.D. Roe Vitamin D status in renal transplant recipients Am. J. Transplant. 7 2007 2546 2552
34. X. Tan, X. Wen, and Y. Liu Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling J. Am. Soc. Nephrol. 19 2008 1741 1752
35. M. Teng, M. Wolf, M.N. Ofsthun, J.M. Lazarus, M.A. Hernan, C.A. Camargo Jr., and R. Thadhani Activated injectable vitamin D and hemodialysis survival: a historical cohort study J. Am. Soc. Nephrol. 16 2005 1115 1125
36. F. Tentori, W.C. Hunt, C.A. Stidley, M.R. Rohrscheib, E.J. Bedrick, K.B. Meyer, H.K. Johnson, and P.G. Zager Mortality risk among hemodialysis patients receiving different vitamin D analogs Kidney Int. 70 2006 1858 1865
37. A. Torres, V. Lorenzo, and E. Salido Calcium metabolism and skeletal problems after transplantation J. Am. Soc. Nephrol. 13 2002 551 558
38. A. Ueno, and S. Oh-ishi Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats J. Pharmacol. Sci. 93 2003 1 20
39. J. Villanueva, J. Philip, D. Entenberg, C.A. Chaparro, M.K. Tanwar, E.C. Holland, and P. Tempst Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry Anal. Chem. 76 2004 1560 1570
40. N. Yao, H. Chen, H. Lin, C. Deng, and X. Zhang Enrichment of peptides in serum by C(8)-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis J. Chromatogr. A 1185 2008 93 101